Healthcare provider profile · identity verified

Janet Talmo, MD

Family Practice · PETOSKEY, MI · NPI 1932152071

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	292	74
Atorvastatin Calcium	Atorvastatin Calcium	274	78
Losartan Potassium	Losartan Potassium	247	68
Amlodipine Besylate	Amlodipine Besylate	150	44
Omeprazole	Omeprazole	129	40
Metoprolol Succinate	Metoprolol Succinate	124	35
Sertraline Hcl	Sertraline Hcl	124	36
Citalopram Hbr	Citalopram Hydrobromide	121	29
Simvastatin	Simvastatin	115	29
Tramadol Hcl	Tramadol Hcl	115	21
Lisinopril	Lisinopril	100	29
Glimepiride	Glimepiride	80	22
Meloxicam	Meloxicam	78	26
Hydrochlorothiazide	Hydrochlorothiazide	76	25
Fluticasone Propionate	Fluticasone Propionate	73	26
Alprazolam	Alprazolam	69	22
Gabapentin	Gabapentin	68	16
Metformin Hcl	Metformin Hcl	68	22
Albuterol Sulfate Hfa	Albuterol Sulfate	64	32
Azithromycin	Azithromycin	64	53
Trazodone Hcl	Trazodone Hcl	62	18
Lorazepam	Lorazepam	58	14
Eliquis	Apixaban	57	16
Carvedilol	Carvedilol	54	14
Furosemide	Furosemide	54	18
Famotidine	Famotidine	50	15
Fluoxetine Hcl	Fluoxetine Hcl	49	14
Pravastatin Sodium	Pravastatin Sodium	48	14
Montelukast Sodium	Montelukast Sodium	47	12
Atenolol	Atenolol	45	11
Metformin Hcl Er	Metformin Hcl	45	16
Pantoprazole Sodium	Pantoprazole Sodium	43	13
Rosuvastatin Calcium	Rosuvastatin Calcium	41	14
Cefuroxime	Cefuroxime Axetil	40	32
Pregabalin	Pregabalin	34	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	34	suppressed
Armour Thyroid	Thyroid,pork	32	suppressed
Clonazepam	Clonazepam	32	suppressed
Prednisone	Prednisone	30	21
Synthroid	Levothyroxine Sodium	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Valacyclovir	Valacyclovir Hcl	29	13
Bupropion Xl	Bupropion Hcl	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Mupirocin	Mupirocin	26	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	16
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Cephalexin	Cephalexin	16	14
Ezetimibe	Ezetimibe	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	13
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error